Therefore, it is considered that the predominance of apoA2-AT/AT (light isoform) or apoA2-ATQ/ATQ (heavy isoform) depends on the increase or decrease in exocrine function of the pancreas in patients with pancreatic cancer and HRIs. The gene discussed is APOA2; the disease is pancreatic neoplasm.